Anticoagulant Therapy: Strategies for Improving Patient Safety. Brought to you by the Washington Patient Safety Coalition September 9 th, 2009

Size: px
Start display at page:

Download "Anticoagulant Therapy: Strategies for Improving Patient Safety. Brought to you by the Washington Patient Safety Coalition September 9 th, 2009"

Transcription

1 Anticoagulant Therapy: Strategies for Improving Patient Safety Brought to you by the Washington Patient Safety Coalition September 9 th, 2009

2 Goals of Presentation Raise awareness and understanding regarding use of FMEA to improve anticoagulation safety. Provide examples of multidisciplinary efforts to improve anticoagulation safety upon transitions in care. Demonstrate value of standardization of products & care processes, role definition and communication methods in improving medication safety.

3 General Topics / Presenters Heparin Products and Infusions Brent Albertson, PharmD,, BCPS Transitions in Care with Anticoagulation Eric Harvey, PharmD,, MBA, BCPS Coordinating Ambulatory Care for Anticoagulation Therapy Elisa Vila, RPh,, CACP

4 Standardizing Heparin Products and Concentrations: An FMEA-directed Improvement Process Brent Albertson, PharmD,, BCPS Advanced Pharmacy Practice Manager Providence Sacred Heart Medical Center & Children's Hospital

5 Providence Sacred Heart Medical Center & Children's Hospital SHMC 623 beds Children s s 120 beds

6 Heparin FMEA Need? Quaid & Texas events Heparin Recall JC Mock Survey Sean Dobbin Director of Pharmacy FMEA

7 Heparin FMEA - Process Leaders Brent Albertson Derek Barnhart, PharmD, Operations Manager Brent Carlson, RPh,, Purchasing Manager Assess Scope Heparin is located all over Many indications therapeutic, prophylactic, flush, line maintenance Process On the Fly (pharmacy centric) Ad Hoc Nurse managers, IV Therapy, & Central Supply Follow up with Tracer activities

8 Heparin FMEA - Process Resources Guidelines & Articles on venous access Key changes IV room change to one concentration Limit number of IV heparin infusion concentrations Heparin in NS, Double strength, unneeded heparin infusiobn uses 1000unit/ml & 5000 unit/ml look alike Drug dictionary descriptions with common uses Removal of heparin from central supply

9 Standardizing the Transition Between Inpatient and Outpatient Anticoagulation Services September 9, 2009 Eric Harvey, PharmD, MBA Pharmacy Quality Manager

10 Seattle Children s Hospital Pediatric referral center for the WAMI region (WA, AK, MT, ID) 250 inpatient beds 13,500 inpatient admissions >200,000 ambulatory clinic visits Pediatric teaching facility for UW School of Medicine

11 Outline Overview of Seattle Children s anticoagulation safety program Seattle Children s approach to standardizing the inpatient-to-outpatient transition for anticoagulation services Things that are working well and ongoing challenges

12 Program Overview 2008 TJC National Patient Safety Goal : Reduce harm associated with the use of anticoagulation 2009: Seattle Children s Hospital launches organization-wide anticoagulation safety program centered on pharmacist-prescribed anticoagulation dose adjustment and monitoring January - Inpatient services offered for patients on heparin, enoxaparin, warfarin April - Transition process for enoxaparin and warfarin patients moving from inpatient to outpatient implemented May Moved existing warfarin clinic outpatients to pharmacy-based service

13 Inpatient to Outpatient Transition Nursing-based discharge education No standard process followed Opportunity to standardize discharge education and transition to outpatient care at the same time One day event on Oct. 31, 2008 Std teaching materials Std documentation method Method for alerting educators of need to teach

14 Inpatient to Outpatient Transition Teaching materials Specific information packets for warfarin and enoxaparin Demonstration/practice kit for enoxaparin injections Defined roles for teaching Nursing Pharmacist Dietitian Standard documentation method Method for alerting educators of need to teach

15 Inpatient to Outpatient Transition Process steps 1. Orders in tx initiation order set

16 Inpatient to Outpatient Transition Process steps 2. D/C criteria order placed on nurse task list 3. Nurse posts bedside checklist

17 Inpatient to Outpatient Transition Process steps 4. Nursing contacts pharmacy (and dietitian) when patient and guardian ready for teaching 5. Pharmacist does teaching and documents in CIS and on bedside checklist 6. Patient discharged with follow-up scheduled

18 Successes and challenges +The educational materials are very well received by patients and families +Everybody likes having very clear roles and responsibilities +Transitions are flowing very smoothly, nobody has been missed/dropped -Difficult for nursing staff to give pharmacy adequate notice when a patient is ready for teaching

19 Questions

20 A Collaborative Process for the Management of VTE Prophylaxis Following Joint Replacement Surgery Elisa Vila, RPh,, CACP Anticoagulation Clinic/Lipid Management Clinic Evergreen Healthcare

21 EVERGREEN HEALTHCARE Kirkland, Washington EHMC is a 280 bed hospital with 16 primary and specialty care clinics 55,000 annual ED visits 4500 annual births Inpatient and outpatient hospice Home Health Service

22 Evergreen Healthcare Anticoagulation Clinic Outpatient service 38,000 annual visits >85% of visits are in clinic FTEs = 9 pharmacist, 4.5 support staff

23 ACC Standard of Care In clinic visit Optimal clinician assessment Reliable laboratory testing and quality control Education opportunities Instruction and follow-up Reimbursement

24 Alternate Management Approach Telephone management Difficulty obtaining lab results Wide variety of home nursing services with varying procedures. Inconsistent patient assessment Difficult communication Dosing errors Reimbursement

25 The Problem The standard of care for telephone managed patients was widely inconsistent and did not meet our quality expectations. The Orthopedic surgeons identified deficiencies in their management of DVT prophylaxis following joint replacement surgery and requested involvement from the Anticoagulation Clinic.

26 Evergreen Home Health 700 patient service 70 RNs along with PT, OT and social work Serving King and Snohomish Counties

27 Program Development Collaborative process with Evergreen Home Health, physician, ACC and laboratory involvement. Protocol development to define treatment parameters and various responsibilities at discharge. Standard discharge orders created for the Joint Replacement program.

28 Evergreen Joint Replacement Discharge Orders

29 Evergreen Joint Replacement Discharge Orders

30 Training Training provided to EHH nursing staff by ACC pharmacists. Coaguchek POC device training Assessment expectations Additional education provided to the team leaders and clinical manager. Responsible nursing manager identified to coordinate ongoing RN training.

31 Results INR results are immediately available. RN assessment is thorough and meets our expectations. Prompt identification of thromboembolic complications. Compliance concerns are addressed. Quality testing and assessment mechanisms are in place. Limited use of outside nursing services. Physician, patient and nursing satisfaction

32 For More Information on the Evergreen Program Don Briggs, RPh,, Manager, Pharmacy Clinical Services; Evergreen Healthcare Ph: ; Fax: Margo Hollenbeck, RPh,, CACP or Elisa Vila, RPh,, CACP Anticoagulation Clinic & Lipid Clinic Ph: ; Fax:

33 Information & Resources Washington Patient Safety Coalition Today s s slide set Tools from presenters Anticoagulation Safety Information IMSP.org (Institute for Safe Medication Practices; type in key word anticoagulation jointcommission.org (The Joint Commission); type in key word anticoagulation

34 Your turn. Questions

35 Thanks to Brent, Eric and Elisa! Please submit your evaluations

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach. Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight

More information

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Presented by Susan Haviland, BSN RN Senior Consult, Santa Rosa Consulting Meaningful Use Quality Measures Centers for Medicare and Medicaid Services

More information

October 8-9, 2015 AAHP Fall Seminar A SCORING SYSTEM IN THE EMR TO FACILITATE PHARMACIST MONITORING OF ANTICOAGULANTS

October 8-9, 2015 AAHP Fall Seminar A SCORING SYSTEM IN THE EMR TO FACILITATE PHARMACIST MONITORING OF ANTICOAGULANTS October 8-9, 2015 AAHP Fall Seminar A SCORING SYSTEM IN THE EMR TO FACILITATE PHARMACIST MONITORING OF ANTICOAGULANTS Disclosures I have no relevant financial relationships to disclose. Baptist Health

More information

Disclosure. Meaningful use 2009. Objectives. Meaningful use. Fundamentals of Transitions of Care (TOC)

Disclosure. Meaningful use 2009. Objectives. Meaningful use. Fundamentals of Transitions of Care (TOC) 47 th Annual Meeting August 2-4, 2013 Orlando, FL Fundamentals of Transitions of Care (TOC) Rebecca R. Prevost, B.S., Pharm.D., PSO Medication Safety Officer Florida Hospital Disclosure I do not have a

More information

PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults

PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults PROTOCOL NUMBER: 7 PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults THIS PROTOCOL APPLIES TO: UW Health Clinics: all adult outpatients with an active order for warfarin TARGET

More information

Overview of the TJC/CMS VTE Core Measures

Overview of the TJC/CMS VTE Core Measures Overview of the TJC/CMS VTE Core Measures CMS Specification Manual 4.2 January 1, 2013 June 30, 2013 Victoria Agramonte, RN, MSN Project Manager, IPRO VTE Regional Learning Sessions NYS Partnership for

More information

PRESCRIBING GUIDELINES FOR THE MANAGEMENT OF PATIENTS ANTICOAGULANT THERAPY

PRESCRIBING GUIDELINES FOR THE MANAGEMENT OF PATIENTS ANTICOAGULANT THERAPY PRESCRIBING GUIDELINES FOR THE MANAGEMENT OF PATIENTS ON ANTICOAGULANT THERAPY Prepared by: NPSA Anticoagulation Steering Group Approved by: Wirral Drug & Therapeutics Committee 14 th May 2008 Review:

More information

Outpatient Anticoagulation Treatment Packet

Outpatient Anticoagulation Treatment Packet Emergency / Pharmacy Services Outpatient Anticoagulation Treatment Packet Check when complete (If indicated): Primary Care Provider Follow Referral to Franciscan Transitional Clinic (if no primary care

More information

(A) Information needed to identify and classify the hospital, include the following: (b) The hospital number assigned by the department;

(A) Information needed to identify and classify the hospital, include the following: (b) The hospital number assigned by the department; 3701-59-05 Hospital registration and reporting requirements. Every hospital, public or private, shall, by the first of March of each year, register with and report to the department of health the following

More information

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March 2007. Action for the NHS and the independent sector

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March 2007. Action for the NHS and the independent sector Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 4 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes

More information

National Patient Safety Goals Effective January 1, 2015

National Patient Safety Goals Effective January 1, 2015 National Patient Safety Goals Goal 1 Nursing are enter ccreditation Program Improve the accuracy of patient and resident identification. NPSG.01.01.01 Use at least two patient or resident identifiers when

More information

Medication Error. Medication Errors. Transitions in Care: Optimizing Intern Resources

Medication Error. Medication Errors. Transitions in Care: Optimizing Intern Resources Transitions in Care: Optimizing Intern Resources DeeDee Hu PharmD, MBA Clinical Specialist Critical Care and Cardiology PGY1 Program Director Memorial Hermann Memorial City Medical Center Medication Error

More information

University of Illinois at Chicago College of Pharmacy. Hospital Compliance with Proposed JCAHO Performance Measures for VTE

University of Illinois at Chicago College of Pharmacy. Hospital Compliance with Proposed JCAHO Performance Measures for VTE 1 Hospital Compliance with Proposed JCAHO Performance Measures for VTE Vikrant Vats, PhD Post Doc Research Associate Center of Pharmacoeconomic Research Background/Rationale Venous thromboembolism (VTE)

More information

Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude..

Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude.. Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude.. Speakers: Sue Dawson, MA, RN, CCRP Clinical Specialist-Cardiology Cam F. Campbell, M.D.

More information

NIMC VTE Prophylaxis Section Audit and Reporting Tool User Guide

NIMC VTE Prophylaxis Section Audit and Reporting Tool User Guide NIMC VTE Prophylaxis Section Audit and Reporting Tool User Guide November 2013 Commonwealth of Australia 2013 This work is copyright. It may be reproduced in whole or in part for study or training purposes

More information

Capturing New Sources of Revenue with a Hospital-Owned Outpatient Pharmacy:

Capturing New Sources of Revenue with a Hospital-Owned Outpatient Pharmacy: Capturing New Sources of Revenue with a Hospital-Owned Outpatient Pharmacy: A White Paper Providing Three Best Practices By Tracy W. Becker, PharmD, and Robert Ketchum, RPh, MS ABSTRACT Faced with another

More information

Evolution of a Closed Loop Medication Use Process

Evolution of a Closed Loop Medication Use Process Evolution of a Closed Loop Medication Use Process Paul J. Vitale, Pharm.D. pvitale@mdmercy.com Vice President and Chief Pharmacy Officer The Mercy Medical Center Baltimore, Maryland Agenda Hospital Background

More information

Service Specification Template Department of Health, updated June 2015

Service Specification Template Department of Health, updated June 2015 Service Specification Template Department of Health, updated June 2015 Service Specification No. : 2 Service: Commissioner Lead: Provider Lead: Period: Anti-coagulation monitoring Date of Review: 31 st

More information

National Patient Safety Goals Effective January 1, 2015

National Patient Safety Goals Effective January 1, 2015 National Patient Safety Goals Effective January 1, 2015 Goal 1 Improve the accuracy of resident identification. NPSG.01.01.01 Long Term are ccreditation Program Medicare/Medicaid ertification-based Option

More information

a Foundation for Change

a Foundation for Change Continuous Quality Improvement ADEs: Steven Utilizing R. Abel, Measurement PharmD, FASHP as Nital Patel, PharmD. MBA a Foundation for Change Sheri Helms, PharmD Candidate Brian Heckman, PharmD Candidate

More information

Ellen F. Robinson, PT ATC Clinical Quality Specialist Seattle, WA

Ellen F. Robinson, PT ATC Clinical Quality Specialist Seattle, WA Ellen F. Robinson, PT ATC Clinical Quality Specialist Seattle, WA Mission and Priority of care Confidential: Quality Improvement 2 July 2009 Oh I wish I had a toolkit July 2010 AHRQ Toolkit Project July

More information

RIH Transitions of Care Collaboration with Coastal Medical To Improve Transitions for Patients Discharged Hospital To Home

RIH Transitions of Care Collaboration with Coastal Medical To Improve Transitions for Patients Discharged Hospital To Home RIH Transitions of Care Collaboration with Coastal Medical To Improve Transitions for Patients Discharged Hospital To Home Sergio Petrillo, PharmD Clinical Pharmacist Specialist, Rhode Island Hospital

More information

THE 2015 QUALIS HEALTH AWARDS OF EXCELLENCE IN HEALTHCARE QUALITY

THE 2015 QUALIS HEALTH AWARDS OF EXCELLENCE IN HEALTHCARE QUALITY THE 2015 QUALIS HEALTH AWARDS OF EXCELLENCE IN HEALTHCARE QUALITY Since 2002, Qualis Health has presented the annual Awards of Excellence in Healthcare Quality to outstanding organizations in Idaho and

More information

Reducing Adverse Drug Events With Anti Coagulation Clinics. McFarland Clinic. McFarland Protime Clinic 09/05/12

Reducing Adverse Drug Events With Anti Coagulation Clinics. McFarland Clinic. McFarland Protime Clinic 09/05/12 Reducing Adverse Drug Events With Anti Coagulation Clinics Dr. Donald Skinner, MD McFarland Clinic 182 Physicians (149 Shareholders) 40 Mid Level Providers 13 Administrators/Executive Directors 1,200 Support

More information

0.9% Sodium Chloride injection may be used in most cases.

0.9% Sodium Chloride injection may be used in most cases. Table 2. Alternatives to Heparin Sodium in Selected Situations 12-14 Situation Alternative Dose Maintain patency of peripheral venous catheters* 21-26 0.9% Sodium Chloride injection may be used in most

More information

Health Information Technology and the National Quality Agenda. Daphne Ayn Bascom, MD PhD Chief Clinical Systems Officer Medical Operations

Health Information Technology and the National Quality Agenda. Daphne Ayn Bascom, MD PhD Chief Clinical Systems Officer Medical Operations Health Information Technology and the National Quality Agenda Daphne Ayn Bascom, MD PhD Chief Clinical Systems Officer Medical Operations Institute of Medicine Definition of Quality "The degree to which

More information

Coventry Health and Life Insurance Company PPO Schedule of Benefits

Coventry Health and Life Insurance Company PPO Schedule of Benefits State(s) of Issue: Oklahoma PPO Plan: OI08C30050 30 Coventry Health and Life Insurance Company PPO Schedule of Benefits Covered Services Contract Year Deductible For All Eligible Expenses (unless otherwise

More information

PHYSICIANS / SURGEONS

PHYSICIANS / SURGEONS PHYSICIANS / SURGEONS American Academy of Audiology American Academy of Neurology American Academy of Physical Medicine & Rehabilitation American Academy of Ophthalmology Academy of Correctional Health

More information

APP PRIVILEGES IN ORTHOPEDICS

APP PRIVILEGES IN ORTHOPEDICS APP PRIVILEGES IN ORTHOPEDICS Education/Training Licensure (Initial and Reappointment) Required Successful completion of a PA or NP program Current Licensure as a PA or RN in the state of CA Current certification

More information

Transitions in Care Models: Case Studies in Pharmacy Practice. A conversation with Michelle Thoma, PharmD and Desi Kotis, PharmD

Transitions in Care Models: Case Studies in Pharmacy Practice. A conversation with Michelle Thoma, PharmD and Desi Kotis, PharmD Biography: Transitions in Care Models: Case Studies in Pharmacy Practice A conversation with Michelle Thoma, PharmD and Desi Kotis, PharmD Michelle Thoma, RPh, PharmD is Pharmacy Manager, Ambulatory and

More information

Anticoagulant therapy

Anticoagulant therapy Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in

More information

TITLE: Processing Provider Orders: Inpatient and Outpatient

TITLE: Processing Provider Orders: Inpatient and Outpatient POLICY and PROCEDURE TITLE: Processing Provider Orders: Inpatient and Outpatient Number: 13211 Version: 13211.3 Type: Patient Care Author: Janice Dinner; Provider Order Policy Committee Effective Date:

More information

AnMed Health Disparities Dashboard

AnMed Health Disparities Dashboard AnMed Health Quick Facts 588 Bed Acute Care System Level II Trauma Center Emergency Department visits: 112,329 Admissions: 23,489 Active Medical Staff: 455 Employees: 3,511 Source : CY2013 Setting the

More information

2.5mg SC daily. INR target 2-3 30 mg SC q 12 hr or 40mg daily. 10 mg PO q day (CrCl 30 ml/min). Avoid if < 30 ml/min. 2.

2.5mg SC daily. INR target 2-3 30 mg SC q 12 hr or 40mg daily. 10 mg PO q day (CrCl 30 ml/min). Avoid if < 30 ml/min. 2. Anticoagulation dosing at UCDMC (SC=subcutaneously; CI=continuous infusion) Indication Agent Dose Comments Prophylaxis Any or No bleeding risk factors see adult heparin (VTE prophylaxis) IV infusion order

More information

Practice Spotlight. Florida Hospital Orlando Orlando, FL www.floridahospital.com IN YOUR VIEW, HOW WOULD YOU DEFINE THE IDEAL PHARMACY PRACTICE MODEL?

Practice Spotlight. Florida Hospital Orlando Orlando, FL www.floridahospital.com IN YOUR VIEW, HOW WOULD YOU DEFINE THE IDEAL PHARMACY PRACTICE MODEL? Practice Spotlight Florida Hospital Orlando Orlando, FL www.floridahospital.com Craig Coumbe, R.Ph., M.B.A. Director of Pharmacy Rania El Lababidi, Pharm.D., BCSP (AQ ID), AAHIVP Assistant Director, Clinical

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: infusion_therapy_in_the_home 3/1998 2/2016 2/2017 2/2016 Description of Procedure or Service Home infusion

More information

Presented by: Char Brar, ACNP, MS(Chem.), MSN, RN Cardiology Nurse Practitioner JBVAMC, Chicago

Presented by: Char Brar, ACNP, MS(Chem.), MSN, RN Cardiology Nurse Practitioner JBVAMC, Chicago Presented by: Char Brar, ACNP, MS(Chem.), MSN, RN Cardiology Nurse Practitioner JBVAMC, Chicago 200 bed acute care facility 4 Community Based Out-patient Clinics (CBOCs) 58,000 Veterans IN FY 2008 : 768

More information

The Ideal Hospital Discharge. Alayne D. Markland, DO, MSc UAB Department of Medicine Division of Geriatrics, Gerontology, & Palliative Care

The Ideal Hospital Discharge. Alayne D. Markland, DO, MSc UAB Department of Medicine Division of Geriatrics, Gerontology, & Palliative Care The Ideal Hospital Discharge Alayne D. Markland, DO, MSc UAB Department of Medicine Division of Geriatrics, Gerontology, & Palliative Care Why is discharge planning important? Surging interest from professional

More information

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Low Molecular Weight Heparin All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Starting Point Low Molecular Weight Heparin (LMWH): Inhibits factor Xa and factor IIa (thrombin) Small

More information

AMERICAN BURN ASSOCIATION BURN CENTER VERIFICATION REVIEW PROGRAM Verificatoin Criterea EFFECTIVE JANUARY 1, 2015. Criterion. Level (1 or 2) Number

AMERICAN BURN ASSOCIATION BURN CENTER VERIFICATION REVIEW PROGRAM Verificatoin Criterea EFFECTIVE JANUARY 1, 2015. Criterion. Level (1 or 2) Number Criterion AMERICAN BURN ASSOCIATION BURN CENTER VERIFICATION REVIEW PROGRAM Criterion Level (1 or 2) Number Criterion BURN CENTER ADMINISTRATION 1. The burn center hospital is currently accredited by The

More information

!"#$%$&!"'()*+,-".-,/ &01*+("12"31+4156"$,+0"!*7("819".5(<(/4*<("&,5( :(()";(,-40"&,5( !"#$%$&!",/)"'()*+,5(

!#$%$&!'()*+,-.-,/ &01*+(1231+4156$,+0!*7(819.5(<(/4*<(&,5( :(();(,-40&,5( !#$%$&!,/)'()*+,5( submitted anytime during the year to your institution HR/Benefits Office, and the tobacco premium will be waived beginning the first of the month following submission of the form. Important: A member is

More information

Safety indicators for inpatient and outpatient oral anticoagulant care

Safety indicators for inpatient and outpatient oral anticoagulant care Safety indicators for inpatient and outpatient oral anticoagulant care 1 Recommendations from the British Committee for Standards in Haematology (BCSH) & National Patient Safety Agency (NPSA) Address for

More information

Reimbursement for Clinical Pharmacy Services: Is There a Role for Facility Billing?

Reimbursement for Clinical Pharmacy Services: Is There a Role for Facility Billing? Reimbursement for Clinical Pharmacy Services: Is There a Role for Facility Billing? Edith A. Nutescu, Pharm.D., FCCP Laura D. Roller, Pharm.D., BCPS, CACP Current Billing Models: Clinical Pharmacy Services

More information

Title Use of rivaroxaban in suspected DVT in the Emergency Department Standard Operating Procedure. Author s job title. Pharmacist.

Title Use of rivaroxaban in suspected DVT in the Emergency Department Standard Operating Procedure. Author s job title. Pharmacist. Document Control Title Use of rivaroxaban in suspected DVT in the Emergency Department Author Pharmacist Directorate Clinical Support Services Version Date Issued Status 0.1 Oct Draft 2015 1.0 Dec Final

More information

5/21/2012. Perioperative Use Issues. On admission: During hospitalization:

5/21/2012. Perioperative Use Issues. On admission: During hospitalization: Dabigatran and Rivaroxaban: Challenges in the Perioperative Setting Claudia Swenson, Pharm.D., CDE, BC-ADM, FASHP Central Washington Hospital Wenatchee, WA claudia.swenson@cwhs.com Dabigatran and Rivaroxaban:

More information

Overcoming Barriers to Discharge for Home Infusion

Overcoming Barriers to Discharge for Home Infusion VOLUME 19 CORAM S CONTINUING EDUCATION PROGRAM Overcoming Barriers to Discharge for Home Infusion Successful home infusion therapy relies on timely and effective transitions to home. Early identification

More information

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h See EMR adult VTE prophylaxis CI order set Enoxaparin See service specific dosing Assess

More information

Department of Pharmacy Services

Department of Pharmacy Services Department of Pharmacy Services Vision Every patient has access to a pharmacist to optimize their health through medication management and to promote living healthier together. Pharmacy Mission AAMC pharmacy

More information

Technician Learning Objectives 3/25/2014. Pharmacy Practice Changes in ACA Accountable Care Organizations

Technician Learning Objectives 3/25/2014. Pharmacy Practice Changes in ACA Accountable Care Organizations Pharmacy Practice Changes in ACA Accountable Care Organizations Avani S. Desai, PharmD & Emory S. Martin PharmD Sunday, April 12, 2014 9:05 10:05 am Pharmacist Learning Objectives At the conclusion of

More information

ASHP Accredited PGY1 & PGY2 Residency with Master s Degree in Health-System Pharmacy Administration

ASHP Accredited PGY1 & PGY2 Residency with Master s Degree in Health-System Pharmacy Administration ASHP Accredited PGY1 & PGY2 Residency with Master s Degree in Health-System Pharmacy Administration Summary Number of Positions: 4 Application Deadline: January 5. 2015 Starting Date: June 2015 Stipend/Benefits:

More information

PGY-1 General Pharmacy Practice Residency (Inpatient & Outpatient)

PGY-1 General Pharmacy Practice Residency (Inpatient & Outpatient) (Inpatient & Outpatient) PGY-1 pharmacy residency programs at the William S. Middleton Veterans Hospital (also known as the Madison VA ) have been in existence for 30 years and Art Schuna has trained over

More information

National Association for Home Care & Hospice 2014 Annual Meeting

National Association for Home Care & Hospice 2014 Annual Meeting National Association for Home Care & Hospice 2014 Annual Meeting Innovative Incentive Compensation Planning for Home Health Clinicians October 19, 2014 Agenda Introduction Compensation Planning Process

More information

Main Section of the proposal: 1. Overall Aim & Objectives:

Main Section of the proposal: 1. Overall Aim & Objectives: Main Section of the proposal: 1. Overall Aim & Objectives: Over the past two decades Providence Health & Services has developed a comprehensive tobacco cessation program within our health system. The foundation

More information

Conflict of Interest Disclosure

Conflict of Interest Disclosure Leveraging Clinical Decision Support for Optimal Medication Management Anne M Bobb, BS Pharm., Director Quality Informatics Children s Memorial Hospital, Chicago IL, February 20, 2012 DISCLAIMER: The views

More information

Special Topics in Vendor- Specific Systems. Outline. Results Review. Unit 4 EHR Functionality. EHR functionality. Results Review

Special Topics in Vendor- Specific Systems. Outline. Results Review. Unit 4 EHR Functionality. EHR functionality. Results Review Special Topics in Vendor- Specific Systems Unit 4 EHR Functionality EHR functionality Results Review Outline Computerized Provider Order Entry (CPOE) Documentation Billing Messaging 2 Results Review Laboratory

More information

Inpatient Quality Reporting Program

Inpatient Quality Reporting Program Venous Thromboembolism 2015 Abstraction Guidance Questions and Answers Moderator: Candace Jackson, RN Inpatient Quality Reporting Support Contract Lead, HSAG Speakers: Denise Krusenoski, MSN, RN, CMSRN,

More information

Prostate Assessment Pathway Prostate Biopsy Alerts

Prostate Assessment Pathway Prostate Biopsy Alerts Prostate Assessment Pathway Prostate Biopsy Alerts Guidelines for the Management of Patient Preparation, Medications and Complications July 2015 Table of Contents Roles and Responsibilities. 1 SECTION

More information

Z Take this folder with you to your

Z Take this folder with you to your my health care notebook Why? Being an active part of your health care team helps you feel better and helps you get even better care. Starting on Day 1, you can keep track of important information and questions.

More information

2015 Annual Convention

2015 Annual Convention 2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 11:30 am 1:00 pm Location: Gaylord National Harbor Resort and Convention Center, National Harbor 11 Title: Activity Type: Speaker: Managing

More information

Medication Safety Committee Guidelines. Emergency Department Medication Management Safety Tool

Medication Safety Committee Guidelines. Emergency Department Medication Management Safety Tool ication Safety Committee Guidelines Department ication Management Safety Tool TABLE OF CONTENTS REVISION LOG... 2 INTRODUCTION... 3 COMMITTEE REPRESENTATION... 3 EMERGENCY DEPARTMENT MEDICATION MANAGEMENT

More information

LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER - SHREVEPORT MEDICAL RECORDS CONTENT/DOCUMENTATION

LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER - SHREVEPORT MEDICAL RECORDS CONTENT/DOCUMENTATION LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER - SHREVEPORT MEDICAL RECORDS CONTENT/DOCUMENTATION Hospital Policy Manual Purpose: To define the components of the paper and electronic medical record

More information

Licensure. Registered Pharmacist New York - License number 043093. Certifications. WMD Cardiology ACLS / PALS Pharmacist Immunizer

Licensure. Registered Pharmacist New York - License number 043093. Certifications. WMD Cardiology ACLS / PALS Pharmacist Immunizer Danielle Longo, BS, RPh, PharmD 19 Noble Street Lynbrook, NY 11563 Home: 516-887-4998 Cell: 917-922-9550 Fax: 516-887-1110 dlongo@me.com danielle.longo@astrazeneca.com Licensure Certifications Registered

More information

Formulary Management

Formulary Management Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective

More information

2. Background This indication of rivaroxaban had not previously been considered by the PBAC.

2. Background This indication of rivaroxaban had not previously been considered by the PBAC. PUBLIC SUMMARY DOCUMENT Product: Rivaroxaban, tablets, 15mg and 20mg, Xarelto Sponsor: Bayer Australia Ltd Date of PBAC Consideration: March 2013 1. Purpose of Application The application requested the

More information

Optimizing Medication Administration in a Pediatric ER

Optimizing Medication Administration in a Pediatric ER Optimizing Medication Administration in a Pediatric ER ER Pharmacist Review of First Dose Non-Emergent Medications Penny Williams, RN, MS Clinical Program Manager, Emergency Center Children s Medical Center

More information

Objective. Failure Modes & Effects Analysis: A U-500 Insulin Case Study. What is a FMEA? Assembling a Team. Steps to Conducting a FMEA 5/12/2011

Objective. Failure Modes & Effects Analysis: A U-500 Insulin Case Study. What is a FMEA? Assembling a Team. Steps to Conducting a FMEA 5/12/2011 5/12/2011 Objective Failure Modes & Effects Analysis: A U-500 Insulin Case Study Understand the role of a failure mode and effects analysis (FMEA) in developing U-500 insulin use criteria Ryan J. Bickel,

More information

Centricity Enterprise Nursing Workflow Tools

Centricity Enterprise Nursing Workflow Tools GE Healthcare Centricity Enterprise Nursing Workflow Tools The system that supports a critical piece of patient care your nurses. Nurses are the cornerstone of patient care delivery. Their work spans the

More information

A Benefits Realization Management Strategy for EMR Implementation

A Benefits Realization Management Strategy for EMR Implementation A Benefits Realization Management Strategy for EMR Implementation E-Health Conference June 3, 2015 Toronto Convention Center Tammy DeGiovanni, Director Ambulatory Care Dr. Jim King, Physician and CMIO

More information

The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care

The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care November 12, 2013 Caroline Isbey RN, MSN, CDE Associate Director Teresa Gomez Associate Project Director Specialist-SSM Carol

More information

The Impact of Regional Anesthesia on Perioperative Outcomes By Dr. David Nelson

The Impact of Regional Anesthesia on Perioperative Outcomes By Dr. David Nelson The Impact of Regional Anesthesia on Perioperative Outcomes By Dr. David Nelson As a private practice anesthesiologist, I am often asked: What are the potential benefits of regional anesthesia (RA)? My

More information

Building a Specialty Pharmacy Business. Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services

Building a Specialty Pharmacy Business. Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services Building a Specialty Pharmacy Business Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services Overview Agenda Brief overview of Fairview Barriers for hospital/health

More information

OUTPATIENT HEALTH RECORD FORMAT. 2. Consent to Minor Surgical or Invasive Procedure. 3. Consent for Disclosure of Information

OUTPATIENT HEALTH RECORD FORMAT. 2. Consent to Minor Surgical or Invasive Procedure. 3. Consent for Disclosure of Information OUTPATIENT HEALTH RECORD FORMAT The Health Record is arranged in reverse chronological order from the current date to the date of admission. SIDE I: Administrative Section 1. Refusal of Treatment 2. Consent

More information

How To Plan A Rehabilitation Program

How To Plan A Rehabilitation Program Project Plan to Rehabilitation Service Connecting and Collaborating in the Continuity of Care in Rehabilitation Presented By: Arlene Whitehead, May 31, 2011 Rehabilitation Collaborative Overview OUTLINE

More information

SUBJECT: Final CRNP Regulations Pennsylvania State Board of Nursing

SUBJECT: Final CRNP Regulations Pennsylvania State Board of Nursing PACHC Memo 09-04 Applicable for: FQHC Management Team Human Resource Department Physicians Professional Nurses December 22, 2009 TO: Health Center CEOs FROM: Cheri Rinehart, President & CEO SUBJECT: Final

More information

Order and/or Delegated Procedure :

Order and/or Delegated Procedure : MEDICAL DIRECTIVE Guelph Family Health Team Responsible Person: Cathy Brown Approval Date: December 2007 Re-approval date: Approved by: INR CLINIC Medical Directive Number: GFHTMD 020 Review or Revision

More information

Developing Pharmacist-Managed Clinics in the Outpatient Setting

Developing Pharmacist-Managed Clinics in the Outpatient Setting Developing Pharmacist-Managed Clinics in the Outpatient Setting Name : R Mohd Khairul Anuar R Ismail Unit : Drug Information Unit Preceptor : Pn Zalina Zahari A Primer for Developing Pharmacist- Managed

More information

Advancing Pharmacy Practice via Privileging and Credentialing

Advancing Pharmacy Practice via Privileging and Credentialing Advancing Pharmacy Practice via Privileging and Credentialing Ohio Society of Health-System Pharmacists 75 th Annual Meeting April 10, 2014 L Jake Childs, PharmD, BCPS (PGY2 HSPA Resident, Akron General

More information

Be it enacted by the People of the State of Illinois,

Be it enacted by the People of the State of Illinois, AN ACT concerning public health. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 10. The Sexual Assault Survivors Emergency Treatment Act is amended by

More information

Vertebral Fragility Fracture

Vertebral Fragility Fracture CLINICAL PATHWAY Musculoskeletal Health Vertebral Fragility Fracture Vertebral Fragility Fracture Table of Contents (tap to jump to page) INTRODUCTION 1 Key Points of the Vertebral Fragility Fracture Pathway

More information

2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies

2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies 2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies Legislative Authority: Health Insurance Act (Standard Hospital Benefit) Regulations 1971- Section 3(xv) This schedule lists the

More information

PGY-1 PHARMACY RESIDENCY

PGY-1 PHARMACY RESIDENCY PGY-1 PHARMACY RESIDENCY PGY-1 Match Number: 135413 Program Description and Requirements Providence Health System (PAMC) in Anchorage consists of 394 acute care beds and is part of an integrated health

More information

Tips, Tricks and Traps Practical Insights into 340B

Tips, Tricks and Traps Practical Insights into 340B Tips, Tricks and Traps Practical Insights into 340B Assessing the Opportunity in Ambulatory and Specialty Pharmacy Kevin Scheckelhoff, RPh, MBA Asst. Vice President 340B Solutions, McKesson Chris Shain,

More information

Αthina Triantafyllidi, Director IDIKA S.A

Αthina Triantafyllidi, Director IDIKA S.A Αthina Triantafyllidi, Director IDIKA S.A The Greek eprescription System is a nationwide widespread web based application for the creation, transmission, dispensing and monitoring of medicine prescriptions

More information

What You Need to KnowWhen Taking Anticoagulation Medicine

What You Need to KnowWhen Taking Anticoagulation Medicine What You Need to KnowWhen Taking Anticoagulation Medicine What are anticoagulant medicines? Anticoagulant medicines are a group of medicines that inhibit blood clotting, helping to prevent blood clots.

More information

Introduction. Background to this event. Raising awareness 09/11/2015

Introduction. Background to this event. Raising awareness 09/11/2015 Introduction Primary Care Medicines Governance HSCB Background to this event New class of medicines Availability of training Increasing volume of prescriptions Reports of medication incidents Raising awareness

More information

Glossary of Terms IHealth and the Electronic Health Record

Glossary of Terms IHealth and the Electronic Health Record Activation: The time that a specific site or region will start to use new information system functionality. See also: Go-live, Implementation. Ad-Hoc Charting Allows for entry of static, point-in-time

More information

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014

UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,

More information

What do ACO s and Hospitals want from SNF s and CCRC s

What do ACO s and Hospitals want from SNF s and CCRC s What do ACO s and Hospitals want from SNF s and CCRC s Presented to the Institute of Senior Living, April 11, 2013 A Division of Kindred Healthcare 1 Assessing the match: What hospitals and ACO s currently

More information

Combined Assessment Program Summary Report. Evaluation of Pressure Ulcer Prevention and Management at Veterans Health Administration Facilities

Combined Assessment Program Summary Report. Evaluation of Pressure Ulcer Prevention and Management at Veterans Health Administration Facilities Department of Veterans Affairs Office of Inspector General Report No. 14-05132-90 Office of Healthcare Inspections Combined Assessment Program Summary Report Evaluation of Pressure Ulcer Prevention and

More information

UW MEDICINE PATIENT EDUCATION. Your Care Team. Helpful information

UW MEDICINE PATIENT EDUCATION. Your Care Team. Helpful information UW MEDICINE PATIENT EDUCATION Your Care Team Helpful information In this section: You: The Patient Medical Staff Nursing Staff Allied Health Professionals Support Staff Peer Mentors for People with Spinal

More information

A pharmacist s guide to Pharmacy Services compensation

A pharmacist s guide to Pharmacy Services compensation Alberta Blue Cross Pharmaceutical Services A pharmacist s guide to Pharmacy Services compensation 83443 (2015/12) GENERAL DESCRIPTION... 3 Details... 3 ASSESSMENT CRITERIA... 3 Assessment for a Prescription

More information

Intake / Admissions Processes

Intake / Admissions Processes Intake / Admissions Processes Now that the elements of providing quality customer service have been reviewed, the intake and admission processes will be covered. Some homecare companies make a distinction

More information

Specialty Pharmacy Definition

Specialty Pharmacy Definition Isn t All of Special? Developing Services Presented to: 2015 ICHP Annual Meeting Presented on: September 10, 2015 Presented by: Lana Gerzenshtein, Pharm.D., BCPS The speaker has no conflicts of interest

More information

Evaluating the impact of REMS on burden and patient access

Evaluating the impact of REMS on burden and patient access Evaluating the impact of REMS on burden and patient access Doris Auth, Pharm.D. Team Leader, Division of Risk Management Office of Medication Error Prevention and Risk Management Center for Drug Evaluation

More information

INNOVATION TITLE: HOSPITAL: Innovation Category: select all that apply

INNOVATION TITLE: HOSPITAL: Innovation Category: select all that apply *DO NOT fill out this form in your browser. Save the form to your computer and then open to complete. Emergency Care Innovation of the Year Award Submission Form email completed submission forms to urgentmatters@gwu.edu

More information

Introduction of Insulin Pens in Acute Rehabilitation Hospital. Magee Rehabilitation Hospital Philadelphia, Pennsylvania

Introduction of Insulin Pens in Acute Rehabilitation Hospital. Magee Rehabilitation Hospital Philadelphia, Pennsylvania Introduction of Insulin Pens in Acute Rehabilitation Hospital Magee Rehabilitation Hospital Philadelphia, Pennsylvania Richard Pacitti, Pharm.D., M.B.A., FASHP Director of Pharmacy Services June 2015 Team

More information

Helen M. Simpson Rehabilitation Hospital Leveraging IT to Coordinate Care Transitions

Helen M. Simpson Rehabilitation Hospital Leveraging IT to Coordinate Care Transitions Helen M. Simpson Rehabilitation Hospital Leveraging IT to Coordinate Care Transitions All speakers have completed commercial bias disclosure forms and do not have any conflicts of interest Disclosures

More information

New Oral Anticoagulants. How safe are they outside the trials?

New Oral Anticoagulants. How safe are they outside the trials? New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants

More information

How To Manage An Anticoagulant

How To Manage An Anticoagulant PERI-OPERATIVE MANAGEMENT OF PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) TARGET AUDIENCE: All Canadian health care professionals, including primary care physicians,

More information

DVT/PE Management with Rivaroxaban (Xarelto)

DVT/PE Management with Rivaroxaban (Xarelto) DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular

More information